Skip to content

Clinical trials

Completed Thrombocytopenia trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Status: Completed Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20091
20101
20112
20121
20131
20181
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Abbott Medical Devices2
GlaxoSmithKline2
Sanquin Research & Blood Bank Divisions2
AstraZeneca1
Leiden University Medical Center1
Maastricht University Medical Center1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia13
Purpura, Thrombocytopenic, Idiopathic5
Purpura3
Anemia2
Coronary Artery Disease2
Hematologic Diseases2
Hemorrhage2
Hemorrhagic Stroke2
Hemostatic Disorders2
Ischemic Stroke2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.